12 Health Care Stocks Moving In Wednesday's Pre-Market Session

During Wednesday's pre-market session, several healthcare stocks experienced significant volatility. NewGenIvf Group surged 106% to $0.15, while Connect Biopharma Hldgs rose 79.43% to $1.78. Other gainers included Valion Bio and Ernexa Therapeutics. Conversely, Rafael Holdings dropped 32% to $1.38, with Silexion Therapeutics and Pyxis Oncology also declining.

Gainers

NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 106.0% to $0.15 during Wednesday's pre-market session.
Connect Biopharma Hldgs (NASDAQ:CNTB) stock increased by 79.43% to $1.78. The market value of their outstanding shares is at $62.4 million.
Valion Bio (NASDAQ:VBIO) stock moved upwards by 33.86% to $3.79. The market value of their outstanding shares is at $2.5 million.
Ernexa Therapeutics (NASDAQ:ERNA) shares moved upwards by 18.35% to $3.74. The market value of their outstanding shares is at $3.6 million.
Electra Therapeutics (NASDAQ:ETRA) shares moved upwards by 16.74% to $13.25. The market value of their outstanding shares is at $712.4 million.
Nautilus Biotechnology (NASDAQ:NAUT) stock rose 14.3% to $1.56. The company's market cap stands at $173.7 million.

Losers

Rafael Holdings (NYSE:RFL) stock decreased by 32.0% to $1.38 during Wednesday's pre-market session. The market value of their outstanding shares is at $105.5 million.
Silexion Therapeutics (NASDAQ:SLXN) stock decreased by 13.98% to $0.27. The company's market cap stands at $1.7 million.
Pyxis Oncology (NASDAQ:PYXS) shares declined by 13.8% to $2.5. The company's market cap stands at $241.8 million.
Stablecoin Development (AMEX:SDEV) shares declined by 13.15% to $2.84. The market value of their outstanding shares is at $88.6 million.
Profusa (NASDAQ:PFSA) shares declined by 10.14% to $2.04. The market value of their outstanding shares is at $1.3 million.
Kalaris Therapeutics (NASDAQ:KLRS) stock fell 10.01% to $2.61. The market value of their outstanding shares is at $69.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.